By proceeding, you agree to our Terms of Use and Privacy Policy.
Make faster and better informed drug development decisions In partnership with the world’s leading drug development experts to help you keep up with the pace of preclinical and clinical research developments.
25-27 January 2022
The Leading TGF-ß for Immuno-Oncology Summit Returns Exclusively Dedicated to Exploring the Role of TGF-ß in Cancer Therapeutics It is evident that TGF-ß holds exciting therapeutic promise to IO drug developers but with the complexity of this target,
Event Ended
Virtual
Paid
About the Multi-Functional Cell Therapies Summit - the Future of Cell Immunotherapy The future of cell therapies is multi-faceted. At the 2nd Multi-Functional Cell Therapies Summit, we are gathering pioneers at the forefront of development to discuss
24-26 May 2022
With TCEs being studied in both hematological and solid tumors (39 and 34 trials respectively), there are now more than one hundred projects in the preclinical stage.
USA
Boston
26-28 July 2022
The most anticipated event of the mRNA calendar, the mRNA-Based Therapeutics Summit is returning for its second year this July as the comprehensive, industry-leading meeting for mRNA experts; your one-stop-shop for all your mRNA-based vaccine and the
26-29 July 2022
With a plethora of cytokine-based modalities and targets storming across biopharma, the complexities and interactions of cytokines involved in the immune system is an exciting opportunity for all. From understanding biology to discovering and combini
06-09 September 2022
3 years since we last brought the community together in-person in San Diego we are excited to once more unite 600+ ADC enthusiasts at the World’s Definitive Antibody-Drug Conjugate Event.
San Diego
20-22 September 2022
The Newly Re-Branded 13th World Multispecifics Summit is the Only End-to-End Meeting Committed Solely to Advancing the Development of Bi- & Multi-Specific Therapeutics With more clinical candidates and commercial success than ever within this rapidly
25-28 October 2022
The 5th Annual Targeted Protein Degradation Summit is the world leading industry-dedicated conference that spans the full drug development pipeline from discovery through to the clinic addressing key challenges to make this exciting new modality a th
05-08 December 2022
This December, the 4th Annual Gene Therapy for Neurological Disorders meeting is returning to Boston to welcome discovery, preclinical, translational and clinical industry scientists to share, learn and network for the shared goal of successfully and
06-08 December 2022
2021 was a landmark year for clinical readouts within the oncolytic virotherapy field, and now OV developers are poised and ready at the cusp of something remarkable and this promising therapeutic is set to be a critical modality within cancer immuno
24-26 January 2023
Welcome to the 6th DDR Inhibitors Summit! DNA damage response inhibition has amassed a lot of interest over the last decade as it exposes a massive vulnerability in cancer cells. This has a huge potential to treat many types of tumors such as breast
The 6th DDR Inhibitors Summit 2023 is the premier event for pharmaceutical and biotech researchers to discuss advances, challenges, and new solutions in the field of DDR inhibitors.
Boston,
21-23 February 2023
Join us in London this February to connect with those trailblazing the next wave of CAR and TCR based approaches from pre-clinical development with in vivo engineering and regulatory fast-track strategies to streamlined analytics and automation to ma
UK
London
21-23 March 2023
Bringing together both technical and strategic expertise sharing case studies with actionable insights, the 4th RNAi-Based Therapeutics Summit returns to Boston to address the most pressing challenges preventing the widespread adoption of RNAi therap
25-27 April 2023
Welcome to the 5th Annual Cell Engager Summit! Tecytinib’s approval last year has strongly fuelled the mentality that this is the year of cell engager! Bispecifics have led the way and liquid tumors have been hit hard. Now Immunocore and others are s
30-01 June 2023
Join us at the 5th Treg Summit, where we will be discussing the latest advancements in IL-2 and CAR-Treg therapies, and how advanced engineering and product design can enhance their tissue specificity, durability, stability, and safety, thus accelera
26-28 July 2023
The most anticipated event of the mRNA calendar year is back with a bang! The mRNA-Based Therapeutics Summit is returning for its 3rd year this July as the one-stop-shop for all your mRNA needs, showcasing exclusive new data from the movers and shake
02-04 October 2023
Join us for the 14th World Bispecific Summit in 2023, where we celebrate the remarkable advancements and immense potential of bispecific antibody treatments. In this pivotal year, bispecific antibody therapies have emerged as formidable contenders in
10-12 October 2023
Welcome to the mRNA Cancer Vaccine Summit 2023, an extraordinary gathering that brings together pioneers in the field of mRNA cancer vaccines. Set in the vibrant city of Boston, this summit marks a pivotal moment in the community's journey towards gr
16-19 October 2023
Join us at the 14th World ADC San Diego conference, where the revolutionary field of antibody-drug conjugates (ADCs) continues to make remarkable strides in the oncology landscape. In the year 2023, the ADC renaissance reaches new heights with the ea
30-02 November 2023
The 6th Targeted Protein Degradation Summit is the premier event for professionals in the field of protein degradation drug development. Returning to Boston in 2023, this summit has established itself as the longest-standing and most comprehensive ga
07-09 November 2023
Welcome to the 5th Gene Therapy for Neurological Disorders Summit, where groundbreaking advancements in gene therapy for central nervous system (CNS) disorders take center stage. Despite the challenges faced by gene therapy developers in 2022, the re